Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 25, No 5 (February 10), 2007: pp. 604-a
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.09.0258

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atkins, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atkins, C. D.

CORRESPONDENCE

Potential Hazards of Mammography

Carl D. Atkins

South Shore Hematology-Oncology Associates PC, Rockville Centre, NY

To the Editor:

Drs Bradbury and Olopade1 misquote the report of the International Workshop on Screening for Breast Cancer2 when they state that annual mammography "has been shown to provide a mortality benefit for women over the age of 40 years old." That workshop examined breast cancer-specific mortality and concluded that a mortality benefit for women younger than age 50 years could not be demonstrated. Breast cancer-specific mortality was improved in all trials involving women age 50 years to 70 years, but was statistically significant in only two trials. There was insufficient data on patients older than age 70 years. No trial has ever shown an overall mortality benefit from screening mammography. Thus, if there is a detrimental effect of radiation exposure from mammography, even a small effect could offset any benefit of mammography. It is also important to remember that none of the mammographic screening trials examined the effect of yearly exposure to mammography for the 20 to 30 years now recommended for most women. Although participants were followed for more than 10 years, mammograms were generally provided only for the first 5 years. It is therefore conceivable that long-term follow-up of these screening trials may not fully reflect all the potential adverse effects of mammography.

AUTHOR'S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The author indicated no potential conflicts of interest.

REFERENCES

1. Bradbury A, Olopade OI: The case for individualized screening recommendations for breast cancer. J Clin Oncol 24:3328-3329, 2006[Free Full Text]

2. Fletcher SW, Vlack W, Harris R, et al: Report of the International Workshop on Screeening for Breast Cancer. J Natl Cancer Inst 85:1644-1656, 1993[Abstract/Free Full Text]





This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atkins, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atkins, C. D.

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online